Press "Enter" to skip to content

Intra-Cellular drug fails one of two bipolar depression studies; shares fall

The treatment, lumateperone, which is being studied as a monotherapy for the condition, failed to show statistically significant improvement in the disease condition compared to placebo in the trial.

Original source:

Also Read:   Medication use drops when local drugstores close